stockrowMesoblast Limited (MESO) vs Maravai LifeSciences Holdings, Inc. (MRVI)
- Mesoblast Limited MESO 14.23 +0.92%
- Maravai LifeSciences Holdings, Inc. MRVI 7.52 +7.74%
Mesoblast Limited and Maravai LifeSciences Holdings, Inc. are both Biotechnology companies. Mesoblast Limited and Maravai LifeSciences Holdings, Inc. are of similar size ($1.8B and $1.8B). Maravai LifeSciences Holdings, Inc. grew revenue faster over the last twelve months: 10.7% against −26.5%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−30.8% vs −1,091.7%) and the lower return on invested capital (−13.6% vs 0.00%). Across the 18 metrics below, Maravai LifeSciences Holdings, Inc. leads on 10 and Mesoblast Limited on 8.
Valuation
Profitability
| Metric | MESO | MRVI | Biotechnology median |
|---|---|---|---|
| Gross margin | (269.72%) | 39.15% | 68.51% |
| Operating margin | (826.28%) | (45.38%) | 0.00% |
| Net margin | (1,091.71%) | (30.83%) | 0.00% |
| Free cash flow margin | 0.00% | (5.89%) | 0.00% |
| Return on equity | 0.00% | (17.01%) | (51.96%) |
| Return on assets | 0.00% | (9.06%) | (46.06%) |
| Return on invested capital | 0.00% | (13.62%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack